#9916. Management of symptoms, pain and mobility with supplementary managements (including Movardol Forte) in osteoarthrosis: A 6-month, morphology supplement study

September 2026publication date
Proposal available till 25-05-2025
4 total number of authors per manuscript0 $

The title of the journal is available only for the authors who have already paid for
Journal’s subject area:
Medicine
Places in the authors’ list:
place 1place 2place 3place 4
FreeFreeFreeFree
2350 $1200 $1050 $900 $
Contract №9916.1 Contract №9916.2 Contract №9916.3 Contract №9916.4
1 place - free (for sale)
2 place - free (for sale)
3 place - free (for sale)
4 place - free (for sale)

Abstract:
Background: this registry evaluated improvements in osteoarthrosis (Oa) in subjects managed using pharma-standard supplements in 2 daily doses. MetHOdS: the group included management groups using:1) chondroitin-glucosamine; 2) only glucosamine; 3) Movardol Forte sachets, in comparison with; 4) standard management (SM). Other two groups 5) boswellia + ginger extract; and 6) only physiotherapy (drug treatment not associated) were subsequently added. Movardol Forte (leonardo Medica, vinci, Florence, italy) is a new standardized supplement including n-acetyl-d-glucosamine, ginger, boswellia and centella extracts, used to manage symptoms linked to osteoarthrosis. Otherwise healthy subjects with Oa symptoms were evaluated. this study focused on symptoms and on ultrasound changes at the joint structures in 6 months.
Keywords:
Centella; Karnofsky performance status; Knee joint; Osteoarthritis; Pain; Ultrasonography

Contacts :
0